US Supplement Labeling Rules: A Brand Owner's Starting Point

A supplement label sold into the US carries more regulatory weight than the same product's pack copy in many other markets, because the label itself is one of the main places compliance expectations actually show up on a finished product. Treating it as a design step that happens after the formula and packaging are locked is one of the more expensive mistakes a first-time US brand makes.

The label is where your ingredient list, your claims, your serving structure and your required disclaimer all have to sit together and agree with each other. A mismatch between what the front of pack promises and what the panel on the back actually supports is a compliance problem before it is ever a design problem.

This piece walks through what changes for a US pack, and where the responsibility for getting it right sits — with you, the brand owner, supported by your manufacturer's documentation, not owned by the manufacturer on your behalf.

None of what follows is exotic — it is a specific, learnable set of requirements rather than an open-ended legal question. Brand owners who treat it as its own project with its own checklist, rather than a formality bolted onto artwork designed for a different market, tend to move through review with fewer rounds of rework.

A dietary supplement sold in the US carries a Supplement Facts panel, not the Nutrition Facts panel used for conventional food — a distinct format with its own required fields, ordering and layout rules. A brand used to a food-style nutrition panel from another market cannot simply relabel it; the panel has to be built to the supplement-specific format from the start.

Serving size, the ingredient list broken out by active, and the standard panel furniture all follow a specific layout convention, and small formatting choices — line spacing, bolding, panel placement — are part of what makes a panel compliant rather than just legible. This is a genuine format difference, not a cosmetic one, and it needs its own artwork pass rather than a straight adaptation of an EU or UK label.

The panel also has to reconcile exactly with your formulation documentation — the same active levels, the same serving structure, the same units of measure — because a mismatch between the panel and your specification file is one of the first things a proper label review will catch, and one of the more time-consuming things to unwind once artwork is already at proof stage.

Any label claim describing how an ingredient supports normal body structure or function has to carry a specific disclaimer statement making clear the claim has not been evaluated, alongside a second line setting out what the product is not intended to do. This disclaimer is not optional styling — it is a required piece of the label wherever that kind of claim appears.

Get the claims wording settled before the disclaimer placement, not after. Brand owners sometimes treat the disclaimer as a fixed block to drop onto an otherwise-finished layout, only to discover the claim itself needed rewording once a proper review looked at it, which then reopens the whole panel.

It is worth deciding, before the first draft of the panel is built, which claims the brand actually needs on this specific SKU rather than every claim the formulation could theoretically support. A shorter, well-supported claims list clears review faster than a longer one that reads as aspirational, and it gives your artwork a stable target instead of a moving one.

Beyond the Supplement Facts panel itself, a US label needs a clear net quantity statement, a full ingredient statement covering both active and other ingredients, and a name-and-address line identifying the party responsible for the product. None of these are unusual concepts if you already sell into other regulated food or supplement markets, but the specific format and placement rules are US-specific and worth checking against a current template rather than assuming a market you already know translates directly.

The responsible-party address line in particular is worth getting right early, since it is one of the few label elements that ties directly to which entity is answerable for the product once it is on shelf — get proper input on exactly whose name and address that line should carry before artwork is finalised.

Net quantity in particular has its own placement and type-size conventions that differ from a food label's version, and a brand owner used to declaring quantity on a food pack should not assume the same rule carries over to a supplement pack without checking first.

US allergen labeling expectations cover a defined list of major allergens and require them to be called out plainly, in a specific way, wherever they are present as an ingredient or a processing consideration. Brand owners moving a product from another market sometimes assume their existing allergen statement covers this, when the US list and the required phrasing do not map one-to-one onto every other market's version.

This is a detail worth confirming with your own review rather than inferring from a previous market's label, because getting it wrong is a straightforward, avoidable label problem rather than a grey area.

Cross-contact statements — language addressing shared production lines rather than an ingredient itself — follow their own convention too, and are worth confirming separately from the ingredient-level allergen callouts, since the two are easy to conflate on a first pass.

A private-label manufacturer's documentation supports your label review; it does not replace it. Claims, on-pack labelling and US market compliance remain the brand owner's responsibility, and the final decision on label wording, disclaimer placement and claims sits with you and your own advisor, not with your production partner.

A manufacturer confident in its documentation will tell you plainly what it can and cannot confirm about your specific label — specification confirmation and an artwork review against general format requirements, for instance, are reasonable to expect; a ruling on your specific claims is not something a manufacturer should be offering in place of your own review.

This division of labour is not a formality — it is why a private-label relationship works at scale across many brands and SKUs at once: the manufacturer standardises what can be standardised across every order, while the brand owner owns the judgement calls specific to their own claims, positioning and market strategy.

Brand owners moving a range from the EU or UK into the US tend to expect a translation exercise — swap units, adjust wording, keep the layout — when the reality is closer to a different panel format built around different required fields entirely. The Supplement Facts panel, the disclaimer requirement and the responsible-party address line do not have a direct one-to-one equivalent on an EU-style label, so a straight adaptation tends to miss requirements rather than simply looking different.

Budget for a genuinely separate US artwork file rather than a localisation pass on an existing one. Brands that treat the US pack as its own artwork project, reviewed against US-specific requirements from a blank layout, tend to move through label review faster than brands trying to adapt a UK or EU file field by field.

Artwork has to be locked before a print run starts, and that lock point sits inside the same production calendar as everything else — format, packaging and the production slot itself. Lead time on the production side is typically a planning range of 5–12 weeks depending on format, packaging, production slot and destination market, and your label review needs to finish comfortably before that window opens, not race it to the wire.

If your brand differentiates through Make it Yours personalisation — flavour, colour or shape changes on an existing formula — remember that naming and artwork still follow the standard private-label branding process rather than a separate design track, so the same label review timeline applies whether the underlying formula is a catalogue option or a personalised variant.

Before you lock artwork for a US SKU, confirm: the Supplement Facts panel follows the correct format, every structure/function claim carries its required disclaimer, the ingredient statement and net quantity are complete, the responsible-party address line names the right entity, and allergen statements have been checked against the US list specifically rather than carried over from another market.

Start a brief with DAT Supply once your claims and disclaimer wording are settled, and the documentation your manufacturer releases at each production stage can support your own review instead of racing to catch up with a print deadline set before the label was actually finished.